Article Details

Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination ...

Retrieved on: 2021-02-26 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination .... View article details on hiswai: https://www.globenewswire.com/news-release/2021/02/26/2183340/0/en/Assembly-Biosciences-and-Arbutus-Biopharma-Initiate-Phase-2-Clinical-Trial-of-Triple-Combination-Therapy-for-the-Treatment-of-Chronic-Hepatitis-B-Virus.html

Excerpt

February 26, 2021 07:30 ET | Source: Arbutus Biopharma Corporation; Assembly Biosciences, Inc. Trial will evaluate Assembly's core inhibitor candidate ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up